The Lancet Summit: shaping the future of diabetes prevention
Nov 30–Dec 2, 2026 | Sitges, Spain
Register here
Don't miss this unique opportunity to connect with global leaders and help shape the future of diabetes prevention and care.
With 589 million people worldwide living with diabetes (90% of whom have type 2 diabetes) and that figure projected to rise to 853 million by 2050, diabetes is one of the greatest public health threats of our time. Despite the availability of effective treatments for type 2 diabetes, diabetes prevention remains the only solution to protect health-care systems and economies, and reduce the burden of this chronic non-communicable disease on future generations.
Stepping up to meet this challenge, we are proud to announce The Lancet Summit: shaping the future of diabetes prevention, a multidisciplinary conference on diabetes prevention and care hosted by The Lancet Group.
Explore the programme highlights
Our full programme brings together 18 internationally recognised experts and patient advocates to lead discussion on:
- Preventing type 2 diabetes – from early detection and screening to effective prevention strategies
- Delaying type 1 diabetes – examining advances in disease-modifying therapies and approaches to slowing disease progression
- Gestational diabetes – exploring prevention and the transmission of diabetes risk across generations
- Global diabetes prevention – addressing the environmental, socioeconomic and other determinants driving the global burden
- GLP-1 receptor agonists – debating their evolving role in diabetes prevention and management
- Prevention of diabetes complications – considering how earlier intervention can reduce long-term health impacts
Register now to connect with some of the leading voices in the field to share perspectives and help shape the future of diabetes prevention and care. There is plenty of time for networking at the welcome reception, during the poster session and at the optional gala dinner.
Of interest to all with a stake in preventing and managing diabetes, including physicians, medical students, fellows, nurses, dieticians, nutritionists, exercise physiologists, psychologists and behavioural therapists, pharmacists, epidemiologists, public health practitioners and researchers, policy makers, and educators, The Lancet Summit offers a unique opportunity to stay up-to-date with the latest advances in diabetes prevention and care.
Register here to join us in Sitges and be part of shaping the future of diabetes prevention.
- Amanda Adler, UK
- Ana Álvarez Pagola (patient advocate), Spain
- Simon Barquera, Mexico
- Katrien Benhalima, Belgium
- Michael Bergman, Portugal
- Simon Griffin, UK
- Oliwia Kaczmarek, (patient advocate), Poland
- Kamlesh Khunti, UK
- Dianna Magliano, Australia
- Chantal Mathieu, Belgium
- Didac Mauricio, Spain
- Jean Claude Mbanya, Cameroon
- Ranjit Mohan Anjana, India
- Aqsha Nur, Switzerland
- Naveed Sattar, UK
- Jaakko Tuomilehto, Spain
- Anette-Gabriele Ziegler, Germany
- Cuilin Zhang, Singapore
-
David Holmes (Deputy Editor, The Lancet Diabetes & Endocrinology)
Audrey Ceschia (Editor in Chief, The Lancet Public Health)
Alex Tosun (Senior Editor, The Lancet)
Callam Davidson (Deputy Editor, The Lancet Surgery & Anaesthesiology)
Ari Colosio (Acting Editor-in-Chief, The Lancet Primary Care)
Yaiza del Pozo Martín (Editor-in-Chief, The Lancet Primary Care)
-
Amanda Adler, University of Oxford, UK
Kamlesh Khunti, University of Leicester, UK
Dianna Magliano, Baker Heart and Diabetes Institute, Australia
Chantal Mathieu, KU Leuven, Belgium
Didac Mauricio, Sant Pau Research Institute, Spain